Navigating the Muddy Waters of Vancomycin Nephrotoxicity

Mayo Clin Proc. 2019 Jan;94(1):1-3. doi: 10.1016/j.mayocp.2018.11.012.

Authors

Erin F Barreto¹, Jason N Barreto², Andrew D Rule³

Affiliations

¹ Department of Pharmacy, Mayo Clinic, Rochester, MN; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN. Electronic address: barreto.erin@mayo.edu.
² Department of Pharmacy, Mayo Clinic, Rochester, MN.
³ Division of Nephrology and Hypertension, Division of Epidemiology, Mayo Clinic, Rochester, MN.

PMID: 30611436
DOI: 10.1016/j.mayocp.2018.11.012

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anti-Bacterial Agents
Humans
Kidney Diseases*
Prognosis
Risk Factors
Vancomycin*

Substances

Anti-Bacterial Agents
Vancomycin